Monday, January 25, 2010

FDA Approves Multiple Sclerosis Drug, Ampyra (dalfampridine) Extended-release

From FierceBiotech:

FDA approves Acorda's new MS drug
January 22, 2010 — 4:49pm ET
By John Carroll


The FDA announced Friday afternoon that it has approved Ampyra (dalfampridine) extended-release tablets to improve walking in patients with multiple sclerosis. In clinical trials, patients treated with Ampyra had faster walking speeds than those treated with a placebo. This is the first drug approved for this use.


Read the FierceBiotech full article

Labels: , , , , ,


Post a Comment

<< Home